De Novo Drug Design
Delve into the forefront of pharmaceutical innovation with this curated selection of groundbreaking studies in De Novo Drug Design, showcasing advanced computational techniques and neural network applications.
- Graph Neural Networks for Conditional De Novo Drug Design
- By: Abate, C. et al., 2021
- Journal: Wiley Interdisciplinary Reviews: Computational Molecular Science
- Read: Access the study
- Graph Neural Networks for Automated De Novo Drug Design
- RetroGNN: Approximating Retrosynthesis by Graph Neural Networks for De Novo Drug Design
- Deep Learning Approaches for De Novo Drug Design: An Overview
- By: Wang, M. et al., 2022
- Journal: Current Opinion in Structural Biology
- Read: Access the study
- Graph-based Generative Models for De Novo Drug Design
- By: Xia, X. et al., 2019
- Journal: Drug Discovery Today: Technologies
- Read: Access the study
- De Novo Drug Design Using Reinforcement Learning with Graph-Based Deep Generative Models
- By: Atance, S. R. et al., 2022
- Journal: Journal of Chemical Information and Modeling
- Read: Access the study
- Structure-based De Novo Drug Design Using 3D Deep Generative Models
- Structure-based Drug Design with Geometric Deep Learning
- By: Isert, C. et al., 2023
- Journal: Current Opinion in Structural Biology
- Read: Access the study
- Generating Novel Molecule for Target Protein (SARS-CoV-2) Using Drug–Target Interaction Based on Graph Neural Network
- By: Ranjan, A. et al., 2022
- Journal: Network Modeling Analysis in Health Informatics and Bioinformatics
- Read: Access the study
- Target Specific De Novo Design of Drug Candidate Molecules with Graph Transformer-based Generative Adversarial Networks
- GeoLDM: Geometric Latent Diffusion Models for 3D Molecule Generation
- By: Xu, M. et al., 2023
- Source: In International Conference on Machine Learning
- Read: Access the study , Github
- Geometry-Complete Diffusion for 3D Molecule Generation and Optimization
- ScaffoldGVAE: scaffold generation and hopping of drug molecules via a variational autoencoder based on multi-view graph neural networks
- De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment